Xavier University School of Medicine is happy to announce that the University and the Baruch S. Blumberg Institute (BS/BI) have entered into a collaboration agreement with each other. The BS/BI is a non-profit translation research organization that was founded in 2003 by the Hepatitis B. Foundation. It is located in the United States in the state of Pennsylvania. The goal of the institute is to discover new and innovative ways to manage and cure chronic hepatitis and liver cancer. Currently BS/BI has 32 companies at their center, and a number of these companies have had their research and discoveries approved by the US FDA and have reached $1 billion valuations. Other notable Universities and organizations that have a partnership or agreement with the institute include The University of Pennsylvania, The Pennsylvania Department of Health, and Oxford University.
This agreement will provide Xavier students with a unique and exciting opportunity to participate in research electives alongside scientists in both the academic and commercial fields. Xavier University students will be given the opportunity to perform research studies with emerging tech companies within the medical industry. The students will be given access to state of the art faculties at the institute that will help them perform the most in-depth and innovative research as possible. This experience will allow the students to further enhance their education, by performing research at a high level institute and gaining first hand, real-world knowledge of the research side of the medical industry.
We are excited to have a collaboration agreement with the Baruch S. Blumberg Institute, and are confident that this will be beneficial to our University and students, as well as the Institute itself.